COSCIENS Biopharma Ownership | Who Owns COSCIENS Biopharma?


OverviewRevenueFinancialsChart

COSCIENS Biopharma Ownership Summary


COSCIENS Biopharma is owned by 1.34% institutional investors, and 98.66% retail investors. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.08% of its assets in COSCIENS Biopharma shares.

AEZS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCOSCIENS Biopharma1.34%-98.66%
SectorHealthcare Stocks 47.31%8.01%44.69%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders


Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20223124.00%1,629,26527.38%1120.90%1362.50%8-
Mar 31, 202225-19.35%1,279,067-34.45%136.54%8-20.00%8-
Dec 31, 202131-6.06%1,951,4080.56%166.34%10-9.09%8-11.11%
Sep 30, 202133-13.16%1,940,583-2.66%159.14%11-15.38%9-10.00%
Jun 30, 202138-2.56%1,993,516-0.38%137.42%13-50.00%1066.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index3.66K0.08%-

Recent Insider Transactions


DateNameRoleActivityValue

Insider Transactions Trends


DateBuySell

AEZS Ownership FAQ


Who Owns COSCIENS Biopharma?

COSCIENS Biopharma shareholders are primarily institutional investors at 1.34%, followed by 0% insiders and 0% retail investors. The average institutional ownership in COSCIENS Biopharma's industry, Biotech Stocks , is 45.43%, which COSCIENS Biopharma falls below.

Does Blackrock own COSCIENS Biopharma?

BlackRock is not among the top 10 institutional shareholders of COSCIENS Biopharma.

Who is the top mutual fund holder of COSCIENS Biopharma shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of COSCIENS Biopharma shares, with 0.08% of its total shares outstanding invested in 3.66K COSCIENS Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools